BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25596731)

  • 1. c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia.
    Kübler K; Heinenberg S; Rudlowski C; Keyver-Paik MD; Abramian A; Merkelbach-Bruse S; Büttner R; Kuhn W; Schildhaus HU
    Oncotarget; 2015 Jan; 6(2):825-35. PubMed ID: 25596731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-myc Gene Copy Number Variation in Cervical Exfoliated Cells Detected on Fluorescence in situ Hybridization for Cervical Cancer Screening.
    Zhao WH; Hao M; Cheng XT; Yang X; Wang ZL; Cheng KY; Liu FL; Bai YX
    Gynecol Obstet Invest; 2016; 81(5):416-23. PubMed ID: 26808725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
    Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
    J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
    Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
    Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and overexpression of TP63 and MYC as biomarkers for transition of cervical intraepithelial neoplasia to cervical cancer.
    Zhu D; Jiang XH; Jiang YH; Ding WC; Zhang CL; Shen H; Wang XL; Ma D; Hu Z; Wang H
    Int J Gynecol Cancer; 2014 May; 24(4):643-8. PubMed ID: 24662128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
    Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
    Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
    Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
    Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.
    Gimenes F; Souza RP; de Abreu AL; Pereira MW; Consolaro ME; da Silva VR
    Arch Gynecol Obstet; 2016 Apr; 293(4):857-63. PubMed ID: 26315473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
    Linxweiler M; Bochen F; Schick B; Wemmert S; Al Kadah B; Greiner M; Hasenfus A; Bohle RM; Juhasz-Böss I; Solomayer EF; Takacs ZF
    BMC Cancer; 2016 Aug; 16(1):676. PubMed ID: 27553742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
    Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC
    Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma.
    Sui W; Ou M; Dai Y; Chen J; Lan H; Yan Q; Huang H
    Int J Gynecol Cancer; 2009 Nov; 19(8):1303-6. PubMed ID: 20009881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
    Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
    Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
    Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
    Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction.
    Aoyama C; Peters J; Senadheera S; Liu P; Shimada H
    Diagn Mol Pathol; 1998 Dec; 7(6):324-30. PubMed ID: 10207671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of chromosome 3q26 gain in predicting progression of cervical dysplasia.
    Rodolakis A; Biliatis I; Symiakaki H; Kershnar E; Kilpatrick MW; Haidopoulos D; Thomakos N; Antsaklis A
    Int J Gynecol Cancer; 2012 Jun; 22(5):742-7. PubMed ID: 22635026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR protein expression and gene amplification in squamous intraepithelial lesions and squamous cell carcinomas of the cervix.
    Li Q; Tang Y; Cheng X; Ji J; Zhang J; Zhou X
    Int J Clin Exp Pathol; 2014; 7(2):733-41. PubMed ID: 24551297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities.
    Hopman AH; Smedts F; Dignef W; Ummelen M; Sonke G; Mravunac M; Vooijs GP; Speel EJ; Ramaekers FC
    J Pathol; 2004 Jan; 202(1):23-33. PubMed ID: 14694518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.
    Ziegert C; Wentzensen N; Vinokurova S; Kisseljov F; Einenkel J; Hoeckel M; von Knebel Doeberitz M
    Oncogene; 2003 Jun; 22(25):3977-84. PubMed ID: 12813471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.